Reuters logo
in 7 months
BRIEF-Cadila Healthcare says Zydus gets final USFDA nod for Methotrexate tablets USP
January 18, 2017 / 9:41 AM / in 7 months

BRIEF-Cadila Healthcare says Zydus gets final USFDA nod for Methotrexate tablets USP

Jan 18 (Reuters) - Cadila Healthcare Ltd :

* Says Zydus receives final approval from the USFDA for Methotrexate tablets USP

* Says drug will be produced at group's formulations manufacturing unit at pharma SEZ in Ahmedabad

* Says drug used for treatment of leukemias, lymphnomas, breast cancer Source text: bit.ly/2jxSjTh Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below